Filing Flows › CTS (CTS) › Who owns the stock
Who owns CTS (CTS) stock
262 funds reported CTS (CTS) shares in their latest 13F filings, worth $1.9B in all. The largest holder is BlackRock ($293M). Last quarter 130 funds added to their stakes and 101 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 4,501,796 | $293M | increase | 2026-06-30 |
| Wasatch Advisors LP | 3,402,325 | $200M | decrease | 2026-09-30 |
| Vanguard Group | 2,744,127 | $118M | increase | 2025-12-31 |
| Earnest Partners LLC | 1,651,926 | $108M | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1,260,973 | $82.2M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 1,217,355 | $79.4M | decrease | 2026-06-30 |
| Dimensional Fund Advisors LP | 1,193,348 | $77.8M | decrease | 2026-06-30 |
| State Street | 1,176,885 | $76.8M | increase | 2026-06-30 |
| Gamco Investors, Inc. et Al | 1,170,496 | $76.3M | decrease | 2026-06-30 |
| Brown Advisory | 981,819 | $64.0M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 760,914 | $49.6M | increase | 2026-06-30 |
| Harvey Partners, LLC | 545,231 | $35.5M | decrease | 2026-06-30 |
| London Co of Virginia | 513,204 | $33.5M | decrease | 2026-06-30 |
| Gabelli Funds LLC | 450,000 | $29.3M | decrease | 2026-06-30 |
| Charles Schwab Investment Management | 409,614 | $26.7M | decrease | 2026-06-30 |
CTS' latest quarter
CTS, Q3 2026: revenue $150M (+5% year over year), operating margin 17.1%, net earnings $17.8M, operating cash flow $43.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CTS stock?
By the latest 13F filings: BlackRock ($293M); Wasatch Advisors LP ($200M); Vanguard Group ($118M); Earnest Partners LLC ($108M); Vanguard Portfolio Management LLC ($82.2M).
What is the short interest in CTS?
1,130,537 shares were sold short at the 2026-10-15 settlement, 4.9% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.